2025 International Congress » Parkinson's Disease: Cognition / Psychiatric Manifestations / Lewy Body Dementia

Meeting: 2025 International Congress

A Four-Arm Randomized Controlled Trial on the Effects of Multi-Dimensional Cognitive Intervention in Parkinson’s Disease with Mild and Subjective Cognitive Decline (REMIND)

P. Huang, C. Gao, YY. Tan, SD. Chen (Shanghai, China)

A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson’s Disease

A. Eubank, A. Thatikala, M. Garza, H. Khan, T. Virmani, R. Dhall, J. Talburt, L. Larson-Prior, F. Prior (Little Rock, USA)

Aberrations in Voluntary Thought Initiation: Parallels to Motor Freezing in Basal Ganglia Dysfunction

S. Shugar, N. Choudhury, D. Nolasco, B. Carr (Gainesvile, USA)

Ameliorating effect of linalool on anxiety disorders in Parkinson’s mice and related mechanisms

F. Lou, M. Li (Shenyang, China)

Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.

A. Lázaro Figueroa, P. Reyes-Pérez, A. Morales, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, N. Gandarilla-Martínez, K. Salinas-Barboza, D. Oropeza, J. Esquivias, I. Hernández-Ruiz, G. de Anda, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (CDMX, Mexico)

Approaches to understanding the role of STN in the development of ICD in Parkinson’s disease

A. Buniak, V. Bayarchyk, A. Mikitchuk (Minsk, Belarus)

Are Hallucinations in Parkinson’s Driven by Over-Reliance on Prior Information?

A. Holden, M. Macaskill, D. Myall, C. Le Heron, S. Lewis, T. Anderson, K-L. Horne (Christchurch, New Zealand)

Atypical Psychosis in Parkinson Disease: A Retrospective Study on 24-Hour Continuous Subcutaneous Infusion Foslevodopa/Foscarbidopa Therapy

K. Ikenaka, K. Kakuda, Y. Kimura, H. Mochizuki (Suita, Japan)

Auditory Musical Hallucinations in Parkinson’s disease: A Case Series

T. Torabi, I. Bledsoe (San Francisco, USA)

Baseline brain inflammation is associated with less cognitive progression at 24 months in subjects with de novo Parkinson’s disease

T. Yacoubian, N. Stover, M. Dean, A. Amara, L. Ruffrage, H. Qin, E. Benveniste, Y. Fang, J. Mcconathy, Y. Zhang, R. Kennedy, A. Gerstenecker, D. Standaert (Birmingham, USA)

Baseline cerebrospinal levels of p-tau and amyloid beta and striatal dopamine transporter binding predict mild cognitive impairment and dementia diagnosis in Parkinson’s disease

L. Collins-Praino, A. Mcnamara, I. Baetu (Adelaide, Australia)

Caution in the creation of Parkinson’s disease cognitive composites

D. Gonzalez, A. Karstens, J. Fleisher, S. Patel, C. Goetz (Chicago, USA)

Cerebral Vasoreactivity and Neuropsychiatric Features in Parkinson’s disease.

M. Cansino Torres, D. Ortiz Zacarias, S. Castillo Torres, R. Lopez Soto, J. Trejo Ayala, A. Infante Valenzuela, F. Gongora Rivera, B. Chavez Luevanos, I. Estrada Bellmann (Monterrey, Mexico)

Changes in Cognitive Function with Deep Brain Stimulation in PD patients with and without Freezing of Gait

V. Basavatia, K. Kwei (New York, USA)

Characteristics of apathy in clinical forms of Parkinson’s disease

O. Naimov, R. Matmurodov, S. Jumanazarova, B. Muminov (Tashkent, Uzbekistan)

Characteristics of Visual Hallucinations in Lewy Body Dementia

Y. Luo, RY. Lo, J. Wang (Hsinchu, Taiwan)

Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

Cognitive and Neuropsychiatric Dysfunction is Associated with Corticostriatal Synucleinopathy in the Alpha-Synuclein Preformed Fibril Rat Model of Parkinson’s Disease

J. Bechtold, J. Patterson, C. Kemp, A. Stoll, S. Arrington, M. Venard, L. Mayle, V. Field, J. Holden, C. Sortwell, S. Fleming (Rootstown, USA)

Cognitive Assessment in Parkinson’s Disease: A Mixed Methods Study of Current Neuropsychology Practices in Australia

J. King, D. Pourzinal, J. Yang, D. Brooks, D. Sriram, K. Sivakumaran, L. Mitchell, N. Dissanayaka (HERSTON, Australia)

Cognitive Biases in Movement Disorders: Implications for Clinical Decision-Making and Patient Perception of Symptoms

N. Choudhury, D. Buonadonna, B. Carr (Gainesvile, USA)

Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)

Cognitive Improvement in Parkinson’s Disease Patients After Intravenous Mesenchymal Stem Cell Infusion: Results from a Phase 2 Randomized Trial

T. Thomas, J. Martinez-Lemus, E. Tharp, C. Green, C. Onuigbo, J. Suescun, T. Le, E. Rodarte Rascon, R. Ritter Iii, T. Ellmore, M. Schiess (Houston, USA)

Comparative Analysis of MoCA Scores Between Latin American Latinos and White Patients with Parkinson’s Disease

S. Sperling, S. Anis, H. Mauricio Chaparro-Solano, T. Peixoto Leal, C. Sonneborn, C. Callegari Piccini, M. Inca-Martinez, M. Cornejo-Olivas, M. Illanes-Manrique, P. Chana-Cuevas, P. Safie Awad, A. Jimena Hernández-Medrano, A. Cervantes-Arriaga, A. Schuh, C. Rieder, P. Braga-Neto, A. Silva Sena, B. Lopes Santos-Lobato, E. Gatto, G. Alvarado, C. Avila, V. Tumas, M. Paula Foss, V. Borges, H. Ballalai Ferraz, J. Orozco Vélez, B. Muñoz Ospina, S. Moreno, D. Pineda, J. Rios Pinto, P. Olguín, J. Cristobal Nuñez, A. Viñuela, A. Espinal-Martinez, N. Mori, K. Mejía-Rojas, A. Medina-Colque, A. Zuma Rosso, C. Vilaça, E. Ochoa-Valle, I. Cornejo-Herrera, P. Reyes-Perez, A. Lázaro-Figueroa, A. Moraes Alves, R. Gisbert Cury, H. Fernandez, I. Mata (Cleveland, USA)

Comparison of 3 Tests for Subjective Cognitive Complaints in Early Parkinson’s Disease

R. Hoe, S. Ng, R. Chen, X. Choi, D. Heng, S. Neo, K. Tay, W. Au, E. Tan, L. Tan, Z. Xu (Singapore, Singapore)

CSF Biomarker-based Cognitive Trajectories in Parkinson’s Disease-Subjective Cognitive Decline

J. Rodriguez-Antiguedad, A. Puig-Davi, I. Ruiz-Barrio, J. Pagonabarraga, A. Vazquez-Oliver, A. Horta-Barba, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

Deep Brain Stimulation Increases Motivation to Obtain Larger Rewards in Parkinson’s Disease

S. Brener, E. Pegolo, A. Hahn, J. Suh, M. Scherbakova, K. Balagula, P. Lockwood, M. Apps, S. Little (Birmingham, United Kingdom)

Demographic Features, QTc Interval and Psychosis in Military Veterans with Parkinson’s disease (PD)

A. Sarwar, P. Bigner (Houston, USA)

Design of the Phase 2, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of ACP-204, a Novel 5-HT2A Inverse Agonist, in Adults With Lewy Body Dementia Psychosis

R. Nunez, S. Friend, B. Howell, S. Pathak, B. Dirks, X. Feng, V. Abler (San Diego, USA)

Determinants of Cognitive Progression in Parkinson’s Disease: A Machine Learning Approach

AJ. Hernández-Medrano, A. Cervantes-Arriaga, MF. Medina-Pérez, D. Ulloa-Hernández, MF. Velasco-Delgado, GA. Martin-Mafud, AE. López-Lobato, D. Náfate-Wences, M. Rodríguez-Violante (Mexico City, Mexico)

Duration of Illness and Response to Pimavanserin in Parkinson’s Disease Psychosis: Post-Hoc Analysis of Clinical Trial Data

K. Dashtipour, A. Espay, M. Tagliati, G. Brunson, X. Feng, N. Rashid, L. Chrones (Loma Linda, USA)

Effect of Systematic Survey-based Screening for Depression in Parkinson’s Disease

M. Super, D. Potts, C. Marshall, N. Dahodwala (Philadelphia, USA)

Episodic Simulation in Parkinson’s Disease (PD)

J. Decker, N. Hantke, E. Leonard (Portland, USA)

Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)

Exploring Uncertainties and Fears of People with Parkinson Disease

P. Gandhi, E. Trahair, D. Steiger, R. Rapoport, L. Chahine, C. Marras, S. Mantri (Edmonton, Canada)

Exploring Visual Scanning Behavior and Novelty Seeking in Parkinson’s Disease: A Pilot Study

K. Paulk, H. Ferguson, L. Neilson, N. Hantke (New Orleans, USA)

Factors contributing to balance discordance and its impact on fear of falling avoidance behavior in Parkinson’s disease

S. Conklin, D. Peterson, A. Hooyman, J. Longhurst (Saint Louis, USA)

Gender Based Differences in Impulse Control Disorders within Parkinson’s Disease

N. David, M. Steinberg, L. Higginbotham, R. Tripathi (Atlanta, USA)

GPi Lesioning vs. DBS: Does Targeting the Same Structure Differently Affect Cognition in Parkinson’s Disease?

J. Brainer, P. Brainer, S. Laurentino, M. Cavalcanti, A. Oliveira, A. Brainer, P. Brainer (Recife, Brazil)

Immune cell changes in early Dementia with Lewy Bodies

T. Yacoubian, H. Qin, A. Amara, N. Stover, L. Ruffrage, M. Dean, Y. Zhang, R. Kennedy, D. Geldmacher, A. Gerstenecker, D. Standaert, E. Benveniste (AURORA, USA)

Impaired glymphatic clearance independently contributes to poor outcomes in Parkinson’s disease

A. Zarkali, G. Thomas, R. Paterson, N. Hannaway, I. Dobreva, A. Heslegrave, E. Veleva, H. Zetterberg, R. Weil (London, United Kingdom)

Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss

M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan (Sunnyvale, USA)

Long-Term Dementia Risk in the General Parkinson Disease Population

J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)

Longitudinal Analysis of Cognitive Changes in Parkinson’s Disease Subjects at Risk of Developing Probable REM Sleep Behavior Disorder (RBD)

A. Basu, J. Ruiz Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)

Machine-learning Prediction of Cognition in Parkinson’s disease: Benchmarking EEG Source Functional Connectivity and Structural MRI

A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, J. Dalrymple-Alford, N. Pat (Christchurch, New Zealand)

Modeling Dementia in Patients with Parkinson’s Disease Years After DBS

S. Gunawardena, E. Assaedi, T. George, C. Sonneborn, D. Floden (Cleveland, USA)

Modified Delphi consensus approach to develop recommendations for diagnosis, evaluation and management of cognitive disorders in Parkinson’s disease

D. Pourzinal, D. Brooks, D. Sriram, L. Mitchell, N. Pachana, K. Shrubsole, B. Wood, J. O'Sullivan, R. Marsh, A. Lehn, J. Liddle, E. Tan, WK. Halford, N. Page, N. Dissanayaka (HERSTON, Australia)

Negative Correlation Between Apathy and Performance on Memory Tasks in Patients with Idiopathic Parkinson’s Disease without Dementia.

J. Felipe Ayala-Rico, C. Alberto Hurtado-González, S. Ospinta-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, K. Valbuena-Epiayu (Cali, Colombia)

Neural Signatures of Hallucination Emergence in Dementia with Lewy Bodies

R. Vin, S. Moret, HY. Yi, M. Lawrence, V. Santini, J. Cedarbaum, A. Powers, C. Fredericks (New Haven, USA)

Neuroimaging and CSF Correlates of Minor Hallucinations in Parkinson’s Disease

E. Hacılar, B. Samancı, U. Ay, S. Yörük, E. şahin, M. Alaylıoğlu, E. Kurt, E. Dursun, H. Gürvit, B. Bilgiç, D. Gezen-Ak, T. Demiralp, H. Hanağası (Istanbul, Turkey)

Neurophysiological research on inhibitory processes in Parkinson’s disease

S. Parmigiani, K. Shultz, N. Swann, . , . (Eugene, USA)

Orthostatic Hypotension and Acute Cognitive Dysfunction in Parkinson’s Disease: Insights from fNIRS

K. Longardner, P. Reddy, M. Skipworth, D. Salmon, K. Izzetoglu, I. Litvan (La Jolla, USA)

Parkinson disease subtype stability and eventual convergence

H. Lessov-Schlaggar, A. Eid, T. Cash, E. Foster, B. Maiti, H. Hwang, R. Perrin, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease

P. Antenucci, M. Sensi, V. Resta, L. Spanedda, D. Zecchinato, G. Linzalone, A. Gozzi, L. Zerbinati (Ferrara, Italy)

Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease

K. Poplawska-Domaszewicz, A. Brek, K. Wu, N. Griffin, S. Fallone, M. Iulita, E. Streel, A. Kurta-Nowicka, K. Naskret-Gasik, J. Konczak, K. Ray Chaudhuri (Poznan, Poland)

Poor sleep quality is one of the causes of cognitive decline in Parkinson’s disease (PD)-1

K. Hasegawa, M. Miyashita, M. Sagawa, A. Kawanami (Kanagawa, Japan)

Positive post-intervention effect of Biodanza therapy on inhibitory control related to the orbitomedial prefrontal cortex.

M. Moreno, M. Aveiga, J. Guapisaca, G. Bueno, M. Pinos (CUENCA, Ecuador)

Predictor of post-deep brain stimulation cognitive decline in Parkinson’s disease patients

L. Montaser-Kouhsari, E. Narinsky, M. Fox (Boston, USA)

Predictors of Health-Related Quality of Life in Parkinson’s Disease: A Five-Year Longitudinal Study

O. Zabala-Gómez, O. Lucas-Jiménez, B. Tijero, I. Gabilondo, J. Peña, N. Ojeda, L. Zubiaurre-Elorza, J. Diez-Huici, M. Acera, R. Del Pino, JC. Gómez-Esteban, N. Ibarretxe-Bilbao (Bilbao, Spain)

Predictors of suicidal ideation amongst people with parkinsonism in the PRIME-UK cross-sectional study

S. Haworth, A. Nodehi, Y. Ben-Shlomo, E. Henderson, E. Tenison (Bristol, United Kingdom)

Prevalence and Management of Depression Among Parkinson’s Patient’s in an Outpatient Clinic Setting

E. Parker, T. Siriwardena (Perth, Australia)

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson’s Disease – A Randomized, Placebo-Controlled Trial (Short Title: ProD)

A. Lemkow, A. Kuan, J. Lam, F. Vila-Rodriguez, M. Mckeown, J. Squires, A. Howard, S. Appel-Cresswell (Vancouver, Canada)

Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

D. Weintraub (Philadelphia, USA)

Psychometric Properties of the SCOPA-Cog Turkish version

S. Isazade, H. Ozden, D. Gunal (Istanbul, Turkey)

Reliability and Validity of In-home Tele-Neuropsychological Testing in Patients with Parkinson’s Disease: A Randomized Trial

S. Sperling, J. Dong, B. Lapin, Y. Li (Cleveland, USA)

Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)

Role of APOE Polymorphism and CSF Markers of AD Co-Pathology in the Cognitive Trajectories of Sporadic and Genetic Parkinson’s Disease: A Longitudinal Cohort Study

R. Botta, J. Locascio, R. Ye, A. Goodheart, S. Gomperts (Boston, USA)

Role of the subthalamic nucleus in working memory in patients with deep brain stimulation for Parkinson’s disease (protocol)

S. Poveda, J. Abril Ronderos, M. Lamprea Rodriguez, O. Bernal-Pacheco (Bogota, Colombia)

Sex Differences for Autopsy-Confirmed Prodromal Lewy Body Dementia

F. Dino, L. Gunn-Sandell, A. Tsai, D. Carter, Y. Wang, E. Bayram (Aurora, USA)

Subthalamic Deep Brain Stimulation Modulates Cognitive-Motor Integration in Parkinson’s Disease: Insights from a Dual-task fNIRS Study

YQ. Zhang, JP. Li, Y. Liang (Beijing, China)

Telephone-Based Cognitive Screening for MCI to Dementia in Parkinson’s Disease

R. Ferrucci, A. de Sandi, F. Verardo, D. Mellace, A. Marfoli, S. Zago, E. Mailland, G. Pravettoni, F. Mameli, F. Ruggiero, E. Zirone, S. Marceglia, A. Priori, F. Cogiamanian, M. Vergari, C. Manzoni, E. Aiello (Milan, Italy)

The Clinical Case of Acute Comorbidities in Parkinson’s Disease

P. Dynin, V. Yakovleva (Saint-Petersburg, Russian Federation)

The Cultural Validation of the Montreal Cognitive Assessment in Bangladeshi Adults with Parkinson’s Disease in East London

K. Dey, A. Shahid, M. Singh, A. Zirra, E. Camboe, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Waters, S. Ali, N. Mukadam, C. Marshall, A. Noyce (London, United Kingdom)